| Patent Number |
Title Of Patent |
Date Issued |
| 7392059 |
Electrical devices |
June 24, 2008 |
| An electrical device such as a portable communications device, domestic or personal care appliance has a main body adapted to couple to an accessory which may be in the form of a tool attachable to the main body or a housing portion. The accessory carries a passive data storage device |
| 7376439 |
Electrical devices |
May 20, 2008 |
| An electrical device such as a portable communications device, domestic or personal care appliance has a main body adapted to couple to an accessory which may be in the form of a tool attachable to the main body or a housing portion. The accessory carries a passive data storage device |
| 7373170 |
Electrical devices |
May 13, 2008 |
| An electrical device such as a portable communications device, domestic or personal care appliance has a main body adapted to couple to an accessory which may be in the form of a tool attachable to the main body or a housing portion. The accessory carries a passive data storage device |
| 7313422 |
Electrical devices |
December 25, 2007 |
| An electrical device such as a portable communications device, domestic or personal care appliance has a main body adapted to couple to an accessory which may be in the form of a tool attachable to the main body or a housing portion. The accessory carries a passive data storage device |
| 7248892 |
Electrical devices |
July 24, 2007 |
| An electrical device such as a portable communications device, domestic or personal care appliance has a main body adapted to couple to an accessory which may be in the form of a tool attachable to the main body or a housing portion. The accessory carries a passive data storage device |
| 7160888 |
[1,8]naphthyridin-2-ones and related compounds for the treatment of schizophrenia |
January 9, 2007 |
| This invention relates to compounds of the formula 1 ##STR00001## wherein G, D, A, Z, Q, X, Y, R.sup.1, and R.sup.4 through R.sup.7 are defined as in the specification, processes for preparing the same and intermediates used in making the same, and pharmaceutical compositions containing |
| 6943183 |
5-substituted tetralones as inhibitors of ras farnesyl transferase |
September 13, 2005 |
| The present invention provides novel 5-substituted tetralones of Formulas I, II, III, and IV and pharmaceutically acceptable salts, esters, amides, and prodrugs thereof, which are useful for treating and preventing uncontrolled or abnormal proliferation of tissues, such as cancer, at |
| 6906092 |
Method of inhibiting matrix metalloproteinases |
June 14, 2005 |
| The present invention relates to a method of inhibiting matrix metalloproteinases using compounds that are dibenzofuran sulfonamide derivatives having the Formula I ##STR1##More particularly, the present invention relates to a method of treating diseases in which matrix metalloprotei |
| 6835131 |
Game apparatus for supplying power to playing elements |
December 28, 2004 |
| A game module has a signal generator for generating a signal for supply to a playing piece when the playing piece is electrically coupled to the games module. The playing piece has a memory for storing data and is arranged to derive a power supply from the signal supplied by the game |
| 6831539 |
Magnetic microactuator for disc with integrated head connections and limiters drives |
December 14, 2004 |
| A microactuator design and fabrication method for an improved magnetic microactuator incorporating mechanical stroke limiters and integrated connections between the flex on suspension and slider. The stroke limiters, also referred to as bumper system, and integrated connections enabl |
| 6624196 |
Benzene butyric acids and their derivatives as inhibitors of matrix metalloproteinases |
September 23, 2003 |
| Benzene butyric acid compounds and derivatives are described as well as methods for the preparation and pharmaceutical compositions of same, which are useful as inhibitors of matrix metalloproteinases, particularly gelatinase A, collagenase-3, and stromelysin-1 and for the treatment of |
| 6624177 |
Matrix metalloproteinase inhibitors and their therapeutic uses |
September 23, 2003 |
| The present invention relates to a method of inhibiting matrix metalloproteinases using compounds that are dibenzofuran sulfonamide derivatives having the Formula I ##STR1##More particularly, the present invention relates to a method of treating diseases in which matrix melatoprotein |
| 6620835 |
Method of inhibiting matrix metalloproteinases |
September 16, 2003 |
| The present invention relates to a method of inhibiting matrix metalloproteinases using compounds that are dibenzofuran sulfonamide derivatives having the Formula I ##STR1##More particularly, the present invention relates to a method of treating diseases in which matrix metalloprotei |
| 6541521 |
Benzene butyric acids and their derivatives as inhibitors of matrix metalloproteinases |
April 1, 2003 |
| Benzene butyric acid compounds and derivatives are described as well as methods for the preparation and pharmaceutical compositions of same, which are useful as inhibitors of matrix metalloproteinases, particularly gelatinase A, collagenase-3, and stromelysin-1 and for the treatment of |
| 6399612 |
Heteroaryl butyric acids and their derivatives as inhibitors of matrix metalloproteinases |
June 4, 2002 |
| Heteroaryl butyric acid compounds and derivatives are described as well as methods for the preparation and pharmaceutical compositions of same, which are useful as inhibitors of matrix metalloproteinases, particularly gelatinase A, collagenase-3, and stromelysin-1 and for the treatment o |
| 6340709 |
Use of matrix metalloproteinase inhibitors for treating neurological disorders and promoting wou |
January 22, 2002 |
| This invention provides a method for treating and preventing neurological disorder such as Alzheimer's disease, and for promoting wound healing comprising administering a compound characterized as being a matrix metalloproteinase inhibitor. |
| 6307089 |
Biphenyl butyric acids and their derivatives as inhibitors of matrix metalloproteinases |
October 23, 2001 |
| Biphenyl butyric acid compounds and derivatives are described as well as acid methods for the preparation and pharmaceutical compositions of same, which are useful as inhibitors of matrix metalloproteinases, particularly gelatinase A (72 kD gelatinase) and stromelysin-1 and for the treat |
| 6265432 |
Flourine-substituted biphenyl butyric acids and their derivatives as inhibitors of matrix metall |
July 24, 2001 |
| Fluorine-substituted biphenyl butyric acid compounds and derivatives are described as well as acid methods for the preparation and pharmaceutical compositions of same, which are useful as inhibitors of matrix metalloproteinases, particularly gelatinase A, stromelysin-1, and collagena |
| 6239288 |
Biphenyl hydroxy imino butyric acids and their derivatives for treating arthritis |
May 29, 2001 |
| Biphenyl butyric acid compounds and derivatives are described as well as acid methods for the preparation and pharmaceutical compositions of same, which are useful as inhibitors of matrix metalloproteinases, particularly gelatinase A (72 kD gelatinase) and stromelysin-1 and for the treat |
| 6169103 |
Fluorine-substituted biphenyl butyric acids and their derivatives as inhibitors of matrix metall |
January 2, 2001 |
| Fluorine-substituted biphenyl butyric acid compounds and derivatives are described as well as acid methods for the preparation and pharmaceutical compositions of same, which are useful as inhibitors of matrix metalloproteinases, particularly gelatinase A, stromelysin-1, and collagena |
| 6008220 |
Aromatic keto-acids and their derivatives as inhibitors of matrix metalloproteinases |
December 28, 1999 |
| Aromatic keto-acid compounds and derivatives are described as well as methods for the preparation and pharmaceutical compositions of same, which are useful as inhibitors of matrix metalloproteinases, particularly gelatinase A (72 kD gelatinase) and stromelysin-1 and for the treatment of |
| 5958972 |
Tricyclic inhibitors of matrix metalloproteinases |
September 28, 1999 |
| Tricyclic compounds are described as well as methods for the preparation and pharmaceutical compositions of same, which are useful as inhibitors of matrix metalloproteinases, particularly gelatinase A (72 kD gelatinase) and stromelysin-1 and for the treatment of multiple sclerosis, a |
| 5693657 |
Heterocyclic-substituted alkyl amide acat inhibitors |
December 2, 1997 |
| Pharmaceutically useful compounds having ACAT inhibitory activity of the formula ##STR1## wherein n is 0, 1, or 2, for X other than tetrazole and n=2 then R.sub.2 .dbd.R.sub.3 .dbd.H; R.sub.1 is phenyl, substituted phenyl, naphthyl, substituted naphthyl, a heteroaromatic group or |
| 5665764 |
Tricyclic inhibitors of matrix metalloproteinases |
September 9, 1997 |
| Tricyclic compounds are described as well as methods for the preparation and pharmaceutical compositions of same, which are useful as inhibitors of matrix metalloproteinases, particularly gelatinase A (72 kD gelatinase) and stromelysin-1 and for the treatment of multiple sclerosis, a |
| 5646170 |
Tetrazole alkyl amide acat inhibitors |
July 8, 1997 |
| Pharmaceutically useful compounds having ACAT inhibitory activity of the formula ##STR1## wherein n is 0, 1, or 2, for X other than tetrazole and n=2 then R.sub.2 .dbd.R.sub.3 .dbd.H; R.sub.1 is phenyl, substituted phenyl, naphthyl, substituted naphthyl, a heteroaromatic group or |
